UT Health San Antonio researchers and collaborators have discovered a set of drugs to fight multiple types of leukemia and lymphoma in adults and children. This new class of drugs targets a survival protein in cancer cells while reducing side effects for patients.

A device for organ and limb preservation developed by a UT Health San Antonio spinoff company could improve the number of successful transplants and organ replacements. The device can preserve tissue for more than 24 hours, which is far longer than current methods.

Are you or a loved one 65 years or older and suffer from Alzheimer’s? This study may be for you. It is designed to determine if the combination of two drugs can help regulate Alzheimer's symptoms in patients.